APP and Alzheimer disease: Herein, we describe one of these molecules, 6-methoxy-2-(4-dimethylaminostyryl) benzofuran (KMS88009), which has an excellent pharmacokinetic profile and significant anti-amyloidogenic effects that ameliorate cognitive impairment in the APP/PS1 double transgenic (TG) mouse model of AD [9].